This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates-revisions: Archive
Toll Brothers (TOL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Toll Brothers (TOL) give a sense of how its business performed in the quarter ended October 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
TOLNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Here's What Key Metrics Tell Us About Ooma (OOMA) Q3 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Ooma (OOMA) give a sense of how the business performed in the quarter ended October 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
OOMAPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
PHRNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Earnings Estimates Moving Higher for Certara (CERT): Time to Buy?
by Zacks Equity Research
Certara, Inc. (CERT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CERTNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Rising for AvePoint (AVPT): Will It Gain?
by Zacks Equity Research
AvePoint, Inc. (AVPT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
AVPTPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Mazda Motor (MZDAY) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Mazda Motor (MZDAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MZDAYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Marvell (MRVL) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Marvell (MRVL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MRVLNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Nokia (NOK) a New Buy Stock
by Zacks Equity Research
Nokia (NOK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NOKPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Andritz (ADRZY) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Andritz (ADRZY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ADRZYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Tilly's (TLYS) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Tilly's (TLYS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TLYSNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Southern Missouri Bancorp (SMBC) Rating Upgrade to Buy
by Zacks Equity Research
Southern Missouri Bancorp (SMBC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SMBCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
CorMedix (CRMD) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
CorMedix (CRMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CRMDPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Donaldson (DCI) Rating Upgrade to Buy
by Zacks Equity Research
Donaldson (DCI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
DCINegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Sally Beauty (SBH) Upgraded to Buy: Here's Why
by Zacks Equity Research
Sally Beauty (SBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SBHNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why
by Zacks Equity Research
PDS Biotechnology (PDSB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PDSBPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Wall Street Analysts Believe AvePoint (AVPT) Could Rally 49.25%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 49.3% upside potential for AvePoint (AVPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
AVPTPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Tango Therapeutics (TNGX) points to a 37.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
TNGXNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think On Holding (ONON) Could Surge 26.11%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for On Holding (ONON) points to a 26.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ONONNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Orla Mining (ORLA) Could Surge 33.33%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 33.3% upside potential for Orla Mining (ORLA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ORLANegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Five9 (FIVN) Could Surge 64.41%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Five9 (FIVN) points to a 64.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
FIVNPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Can Caris Life Sciences,?Inc. (CAI) Climb 32.81% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 32.8% upside potential for Caris Life Sciences,?Inc. (CAI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
CAINegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Certara (CERT) Could Surge 43.28%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 43.3% in Certara (CERT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
CERTNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Prestige Consumer Healthcare (PBH) Could Rally 26.06%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 26.1% upside potential for Prestige Consumer Healthcare (PBH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
PBHNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Hallador Energy (HNRG) Have the Potential to Rally 33.68% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 33.7% upside potential for Hallador Energy (HNRG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
HNRGPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Pony AI Inc. - Sponsored ADR (PONY) Could Rally 70.63%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Pony AI Inc. - Sponsored ADR (PONY) points to a 70.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
PONYPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate